Progress, Potential, and Possibilities Podcast / Show Dr. Andreea-Madalina Serban & Michael Poisel - PhylloPharma - Cost-Effective & Shelf-Stable Proteins
Michael D. Poisel, MS, MBA is Executive Director of PCI Ventures ( https://pci.upenn.edu/entrepreneurs/pci-ventures/ ), a division of the Penn Center for Innovation, specifically focused on creating early-stage businesses founded on University of Pennsylvania technologies. He is responsible for managing PCI Ventures, including transitioning technologies into start-up companies, assisting the principal investigators with funding strategies including grant applications, as well as mentoring the developing companies. Prior to UPenn, Mr. Poisel made investments in enterprise software and business services for NewSpring Capital, Apax Partners and GE Capital spanning more than ten years in private equity. He began his career in manufacturing operations for General Electric/Lockheed Martin and participated in the successful completion of several commercial and government satellite programs. Mr. Poisel graduated with honors in Mechanical Engineering from Rose-Hulman Institute of Technology, holds an M.S. in Systems Engineering from The Moore School of Engineering of the University of Pennsylvania, and has an M.B.A. in finance and entrepreneurial management from The Wharton School of Business of the University of Pennsylvania. Mr. Poisel also serves as the CEO of PCI Ventures spin-out PhylloPharma ( https://www.phyllopharmallc.com/ ), a company developing a novel plant-based technology platform for cost-effective and shelf-stable therapeutic protein delivery. Dr. Andreea-Madalina Serban, MD, Ph.D. ( https://scholar.google.com/citations?user=X8ruFBsAAAAJ&hl=en ) is the Chief Operating Officer of PhylloPharma. Dr. Serban is Medical Doctor specialized in Paediatric Surgery, with a medical degree and Ph.D. from Carol Davila University of Medicine and Pharmacy in Bucharest Romania. Dr. Serban also has a Master's degree in Business Administration - Behavioral Economics from University of Bucharest, a Master of Science - MS, Genetics, from Université Paris Cité, and did Masters Research, Surgical Sciences- Regeneration, Replacement and Tissue Repair, from Paris-Sud University (Paris XI).